Search research articles
Contact Us
Filters
Showing results (1-10 of 75) with videos related to
Page
of 8
Sort By:
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
April 18, 2022
Genomic landscape of sporadic pediatric differentiated thyroid cancers: a systematic review and meta-analysis
Swayamjeet Satapathy, Chandrasekhar Bal
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 24, 2025
Reply to "The Randomized, Phase 2 LuCAP Study"
Swayamjeet Satapathy, Ashwani Sood
Frontiers in Endocrinology
|
July 29, 2022
Theranostic Options for Radioiodine-Refractory Differentiated Thyroid Carcinoma: Recent Advances, Challenges, and Road Ahead
Swayamjeet Satapathy, Chandrasekhar Bal
Nuclear Medicine Communications
|
October 29, 2019
177Lu-DOTATATE peptide receptor radionuclide therapy versus Everolimus in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysis
Swayamjeet Satapathy, Bhagwant Rai Mittal
Clinical Endocrinology
|
October 1, 2019
'Peptide receptor radionuclide therapy in the management of advanced pheochromocytoma and paraganglioma: A systematic review and meta-analysis'
Swayamjeet Satapathy, Bhagwant Rai Mittal, Anil Bhansali
PET Clinics
|
March 1, 2023
Gastro-Enteric-Pancreatic Neuroendocrine Tumor Treatment: Actinium-225-DOTATATE and Combined Therapies
Swayamjeet Satapathy, Kunal Ramesh Chandekar, Chandrasekhar Bal
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 26, 2026
Interpreting Clonal Hematopoiesis Following [<sup>177</sup>Lu]Lu-PSMA-617: Clinical Risk Versus Genomic Signal
Swayamjeet Satapathy, Piyush Aggarwal, Ashwani Sood
Clinical Endocrinology
|
April 9, 2026
Brain Metastases in Differentiated Thyroid Carcinoma: Clinical Features, Treatment Outcomes, and the Role of Radioiodine Therapy
Yogita Khandelwal, Swayamjeet Satapathy, Chandrasekhar Bal
Clinical Nuclear Medicine
|
September 21, 2020
Visceral Metastases as Predictors of Response and Survival Outcomes in Patients of Castration-Resistant Prostate Cancer Treated With 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy: A Systematic Review and Meta-analysis
Swayamjeet Satapathy, Bhagwant Rai Mittal, Ashwani Sood
Clinical Nuclear Medicine
|
January 23, 2025
Utility of Novel Radiohybrid PSMA Ligands in PET Imaging of Biochemical Recurrence of Prostate Cancer-A Systematic Review and Meta-analysis
Kunal Ramesh Chandekar, Swayamjeet Satapathy, Chandrasekhar Bal
Page
of 8
Search research articles
Search
Showing results (1-10 of 75) with videos related to
Sort By:
Page
of 8
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
April 18, 2022
Genomic landscape of sporadic pediatric differentiated thyroid cancers: a systematic review and meta-analysis
Swayamjeet Satapathy, Chandrasekhar Bal
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 24, 2025
Reply to "The Randomized, Phase 2 LuCAP Study"
Swayamjeet Satapathy, Ashwani Sood
Frontiers in Endocrinology
|
July 29, 2022
Theranostic Options for Radioiodine-Refractory Differentiated Thyroid Carcinoma: Recent Advances, Challenges, and Road Ahead
Swayamjeet Satapathy, Chandrasekhar Bal
Nuclear Medicine Communications
|
October 29, 2019
177Lu-DOTATATE peptide receptor radionuclide therapy versus Everolimus in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysis
Swayamjeet Satapathy, Bhagwant Rai Mittal
Clinical Endocrinology
|
October 1, 2019
'Peptide receptor radionuclide therapy in the management of advanced pheochromocytoma and paraganglioma: A systematic review and meta-analysis'
Swayamjeet Satapathy, Bhagwant Rai Mittal, Anil Bhansali
PET Clinics
|
March 1, 2023
Gastro-Enteric-Pancreatic Neuroendocrine Tumor Treatment: Actinium-225-DOTATATE and Combined Therapies
Swayamjeet Satapathy, Kunal Ramesh Chandekar, Chandrasekhar Bal
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 26, 2026
Interpreting Clonal Hematopoiesis Following [<sup>177</sup>Lu]Lu-PSMA-617: Clinical Risk Versus Genomic Signal
Swayamjeet Satapathy, Piyush Aggarwal, Ashwani Sood
Clinical Endocrinology
|
April 9, 2026
Brain Metastases in Differentiated Thyroid Carcinoma: Clinical Features, Treatment Outcomes, and the Role of Radioiodine Therapy
Yogita Khandelwal, Swayamjeet Satapathy, Chandrasekhar Bal
Clinical Nuclear Medicine
|
September 21, 2020
Visceral Metastases as Predictors of Response and Survival Outcomes in Patients of Castration-Resistant Prostate Cancer Treated With 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy: A Systematic Review and Meta-analysis
Swayamjeet Satapathy, Bhagwant Rai Mittal, Ashwani Sood
Clinical Nuclear Medicine
|
January 23, 2025
Utility of Novel Radiohybrid PSMA Ligands in PET Imaging of Biochemical Recurrence of Prostate Cancer-A Systematic Review and Meta-analysis
Kunal Ramesh Chandekar, Swayamjeet Satapathy, Chandrasekhar Bal
Page
of 8